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license (http://creativetive decline. Whether these indicate structural atrophy, which could be screened for at a larger scale
using noninvasive structural imaging, is unknown.
Methods: We assessed annual structural magnetic resonance imaging scans and cognitive data from
3 consecutive years from 204 participants from the AD Neuroimaging Initiative database (mean age
72.24 [8.175] years). We evaluated associations between brain structural changes and performance in
the Montreal Cognitive Assessment, Everyday Cognition Visuospatial subtest (ECog Visuospatial),
and Functional Assessment Questionnaire.
Results: Changes in the surface area of the SFG were associated with changes in the outcome of the
ECog Visuospatial test (P , .05), but an inconsistent pattern of association was found between the 2-
year global brain atrophy progression and changes in the outcome from the three cognitive tests selected.
Discussion: The extent into which (and if) changes in the SFG influence cognition warrant further
evaluation in a larger period in more heterogeneous population.
 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Keywords: Brain; MRI; Superior frontal gyrus; Brain atrophy; Cognitive decline1. Introduction
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commons.org/licenses/by-nc-nd/4.0/).increasing elderly population. Cognitive decline in adult-
hood represents a continuum ranging ‘from normal healthy
aging to mild cognitive impairment (MCI) to dementia
with growing severity in each cognitive grouping. Cognitive
decline has been associated with a global decrease in brain
volume proportionate to the degree of decline seen [1].
One hallmark of cognitive decline is deficits in executive
functioning affecting skills such as working memory, multi-
tasking, and attention [2].The prefrontal cortex has been
widely associated with these functions and therefore linked
to progression of overt manifestation of cognitive
dysfunction.
A study using positron emission tomography scanning
found that metabolic changes in the prefrontal cortex,
including the superior frontal gyrus (SFG), were present inimer’s Association. This is an open access article under the CC BY-NC-ND
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(AD) and absent in nonprogressors [3]. Given the invasive-
ness and expense of positron emission tomography scan-
ning, this study has limited clinical applicability but
indicated that there are specific areas of the brain that may
be of interest in evaluating markers that could be better indi-
cators of the changes across the continuum of cognitive
decline, and that the SFG could be one of these areas. Struc-
tural imaging modalities such as magnetic resonance imag-
ing (MRI) would overcome these practical barriers with their
ease of use, noninvasiveness, and relatively low cost [4].
The SFG is known to be heavily involved in a variety of
cognitive and motor control tasks. The lateral part is thought
to have strong associations with working memory and atten-
tion, with the medial being more influential in other
cognitive-related processing [5,6]. In addition to the study
from Drzezga et al., biochemical and structural changes on
this brain region have been seen in other diseases that
affect cognitive performance such as Parkinson’s disease
and schizophrenia [6]. Cortical thickness is known to be a
very stable parameter [7], which illustrates cellular charac-
teristics such as myelination, cell size, and the number of
cortical neurons [8]. Previous studies have used changes in
cortical thickness to separate patients of different cognitive
capacity and to examine the differences between MCI “pro-
gressors” and “nonprogressors” [7]. Decrease in the SFG
cortical thickness has been associated with declining cogni-
tion [7]. Furthermore, cortical surface area has been well es-
tablished as a sensitive marker to brain structure changes [9].
In normal aging, it is known that the SFG has one of the
greatest age-related surface area reductions in the brain
[10]. Reductions in the surface area have been shown to
correlate with low working memory performance in healthy
populations; however, this has currently not been established
in the context of cognitively impaired demographics [9] and
to the best of our knowledge, it has not been analyzed in the
context of progression to any form of dementia.
Therefore, the goal of this study was to investigate
whether changes in global brain atrophy and SFG structural
measurements were associated with performance on cogni-
tive tests sensitive to cognitive group differentiation and
indicative of cognitive decline. The ultimate aim of the study
was to add to the search for structural brain imaging markers
sensitive to cognitive performance that could be used for
early AD diagnosis.2. Materials and methods
2.1. Subjects
Data were obtained from the Alzheimer’s Disease Neuro-
imaging Initiative (ADNI) database (adni.loni.uk), a large
scale, longitudinal, ongoing collaborative study running
since 2004 focused on finding biomarkers to assist in the
diagnosis and prognosis of cognitive decline (ADNI,
2017). Subjects, aged 55–90 years, were selected from 55sites in the United States and Canada including cognitively
normal (CN) subjects, patients with early MCI (EMCI),
others with late MCI (LMCI) and AD patients. Further infor-
mation about the ADNI study and detail about selection
criteria and protocols can be found at http://adni.loni.usc.
edu/methods/documents/. The database was accessed in
January 2017.
At the time of accessing the database, 204 subjects (IDs
given in Annex 1 for reproducibility purposes) with the
following selection criteria were identified:
 Three consecutive scans acquired exactly 12 months
apart,
 Complete structural MRI data sets with T1-weighted,
T2-weighted, T2*-weighted and Fluid Attenuated
Inversion Recovery MRI sequences at each visit, and
 Cognitive assessments done at the time of each MRI
scan.
The selection and image processing of the MRI scans
were done blind to any clinical, demographic, or cognitive
status/data.
2.2. Cognitive assessments
All participants undertook a wide range of cognitive tests
as described in http://adni.loni.usc.edu/data-samples/
clinical-data/ and http://www.adni-info.org/Scientists/Cogni
tiveTesting.html. For this study, we used the Functional Ac-
tivities Questionnaire, Montreal Cognitive Assessment, and
Everyday Cognition Visuospatial tests, all which were avail-
able for all selected participants at the imaged time points.
Each participant’s cognitive status (i.e., CN, EMCI,
LMCI, and AD) was determined from the results from the
Mini-Mental State Exam (MMSE), Clinical Dementia Rat-
ing score, and the Logical Memory (II) component of the
Wechsler Memory Scale [11], as described in the study by
Aisen et al. [12].
2.3. MRI acquisition
All images were acquired at 3T scanners. Turbo Spin
Echo T2-weighted images were acquired axially, with
echo time (TE)/repetition time (TR) 5 80/3000 ms, flip
angle 90o, matrix 256 ! 256 ! 44, voxel size
0.9375 mm ! 0.9375 mm ! 4 mm. 2D FLAIR images
were also acquired in axial orientation, with TE/TR/
inversion time 5 90/9000/2500 ms, matrix 256 ! 256 !
35, voxel size 0.8594 mm! 0.8594 mm! 5 mm. 2D axial
T2*-weighted images were acquired with TE/TR 5 20/
650.001 ms, matrix 256 ! 256 ! 44, voxel size
0.7812 mm ! 0.7812 mm ! 4 mm, and 3D T1-weighted
MPRAGE sequences were acquired sagittally with TE/
TR 5 3.162/6.818, flip angle 9o, matrix 256 ! 256 !
170, voxel size 1 mm ! 1 mm ! 1.2 mm. These sequence
parameters were consistent with little variations across the
sites. More information about the (ADNI-2 and ADNI-go)
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methods/documents/mri-protocols/.2.4. Image analysis
T1-weighted, FLAIR, and T2*-weighted images were
spatially, rigidly, and automatically aligned to the T2-
weighted using FMRIB’s Linear Image Registration Tool
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLIRT). The intracra-
nial contents were extracted also fully automatically using
BRICbet, a MATLAB function publicly available, which is
part of the library BRIClib (https://sourceforge.net/projects/
bric1936/files/MATLAB_R2015a_to_R2017b/BRIClib/). It
uses either the susceptibility-weighted image (i.e., T2*-
weighted) or a combination of it with a T2-weighted–based
image (i.e., T2-weighted and/or FLAIR), on a pipeline that
involves bias field correction and brain extraction using
BET2 (http://poc.vl-e.nl/distribution/manual/fsl-3.2/
bet2/index.html), followed by first-order statistical manipu-
lations of the intensity of the brain extracted volume, com-
bined with morphological operations. Total cerebrospinal
fluid (CSF) volume and pial structures (e.g., veins and
meninges) were obtained fully automatically from the
MRI scans using multispectral Gaussian Clustering (i.e.,
clustering based on Gaussian Mixture Models using the
Expectation-Maximization algorithm). Brain ventricles
were extracted using nonlinear registration of the regional
brain atlas for assessment of white matter hyperintensities
(http://datashare.is.ed.ac.uk/handle/10283/2217) combined
with the total CSF mask (i.e., which also included pial struc-
tures), also fully automatically as per [13]. All resultant bi-
nary masks were visually inspected and manually
corrected only if and where required using Mango (http://
ric.uthscsa.edu/mango/index.html).
Preliminary analyses of automatic segmentations of the
superior frontal cortex yielded inconsistencies in its bound-
aries for different subjects. Therefore, ground truth segmen-
tations of the superior frontal cortex were generated on a
randomly selected subsample of data sets from 34 subjects
following a detailed protocol based on the Ono [14] and Du-
vernoy [15] brain atlases and considering the recommenda-Fig. 1. Axial T1-weighted slices showing the results of the CSF and SFG cortex seg
matter outer boundary of the SFGwhile blue represents white matter outer boundar
fluid.tions from Mikhael et al. (2017) [16]. Every SFG was
delineated by drawing two open curves; an outer curve for
the gray matter boundary with the subarachnoid space
(red) and another demarcating the inner white matter bound-
ary of the gyrus as Fig. 1 shows. The cortices were
segmented on axial slices of each scan manually using mri-
cron (https://www.nitrc.org/projects/mricron/).
All measurements were done independently at the three
time points: year 1 (Y1), year 2 (Y2), and year 3 (Y3).
The SFG outer boundary was used to calculate the cortical
surface area. The cortical thickness was calculated using
the distance transform of the cortex in the region delineated,
which calculates the Euclidean distance between the inner
and outer boundaries of the SFG at each point. Average
values of the manual segmentations were used in the ana-
lyses. SFG cortical volumes were calculated by multiplying
the SFG surface area by the SFG cortical thickness.2.5. Statistical analyses
CSF was used as a proxy for brain atrophy as any increase
in atrophy would equally give concomitant increases in CSF
volume. We calculated the change in cognitive performance
and brain atrophy measurements (i.e., ventricular CSF vol-
ume, Total CSF volume, and SFG volume all adjusted for
head size, average surface area of the SFG, and mean
cortical thickness of the SFG), as the difference between
the measurements acquired at 2 different years, for example,
(Y22Y1), (Y32Y2), and (Y32Y1). Any positive results
in the global imaging variables and any negative results in
the local SFG measurements indicate an increase in
global/local atrophy, respectively. For the analyses, all brain
volumetric measurements were adjusted for head size by
calculating the percentage they represent in intracranial vol-
ume (ICV). We performed linear regression analyses evalu-
ating fitness to a general linear model using MATLAB
R2014b (stepwiseglm function) to assess the association be-
tween the yearly changes of the atrophy variables obtained,
and the changes in the performance in the selected cognitive
tests, controlling for the confounding effects of age. If an as-
sociation was found, other covariates were subsequentlymentations. Red represents ventricular and total CSF. Yellow represents gray
y of the SFG. Abbreviations: SFG, superior frontal gyrus; CSF, cerebrospinal
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tions of the associations. These were gender, baseline cogni-
tive performance in the MMSE test, years of education,
family history of dementia/AD, and cardiovascular and
endocrino-metabolic risk factors. We used backward step-
wise general linear models to evaluate the results of our
linear model and appraised the model fitness while adding
or removing variables using both the Akaike Information
Criterion and the P value for the chi-squared test of the
change in the deviance by adding or removing the term.
The model with all possible interactions was the largest
model to consider in the evaluation. Paired samples t-test
and correlations were calculated using IBM SPSS Statistics
ver. 21 (release 21.0.0.0, 64 bit ed.) to evaluate differences
between variables and changes between years (nonstandar-
dized correlation coefficients B and P values given). The re-
sults were re-evaluated doing a percentile bootstrap on the
pair difference and adjusted for multiple comparisons using
the Robust Statistical MATLAB Toolbox ([17]—MATLAB
implementation, in//github.com/Cpernet/Robust_Statisti-
cal_Toolbox). Finally, Neurosynth (http://www.neurosynth.
org/) was used to investigate on the positive associations
found. Neurosynth is a platform for automatically synthesiz-
ing the results of meta-analyzing thousands of neuroimaging
studies [18]. We queried the term-based meta-analyses data-
base for the cognitive function(s) that resulted associated
with the brain imaging variable(s) analyzed. Such query trig-
gers a giant meta-analysis comparing the coordinates re-
ported for studies with and without the term entered,
producing statistical inference maps and posterior probabil-
ity maps that display the likelihood of a given term being
used in a study if activation is observed at a particular voxel.3. Results
The sample included 71 CN, 65 EMCI, 61 LMCI, and 7
ADADNI participants with mean age of 72.24 (8.175) years.
Age, gender, and years of education were balanced among
cognitive groups. Detailed demographics for each cognitive
group can be seen in Supplementary Table S1 (Annex 2).
The median number of cardiovascular risk factors (0:
none, 1: cardiovascular disease or smoking, 2: both) was
one across the four cognitive groups. None of the individuals
who provided data for this analysis changed the cognitive
group within the period analyzed.
The descriptive statistics of the imaging and cognitive pa-
rameters explored are shown in Table 1 and illustrated in
Supplementary Figs. S2–S10 of Annex 2. The average sur-
face area in the SFG decreased in LMCI and AD patients
over the 2 consecutive years analyzed but the pattern was
inconsistent in CN and EMCI groups. SFG surface area mea-
surements at each year were highly correlated
(0.85 , B , 0.89, P , .0001) and yearly changes were
not significant (Y1/Y2 confidence interval (CI)
[2400 1 1016] P 5 .4, Y2/Y3 CI [2877 1 381]
P5 .4, and Y1/Y3 CI [26251 754] P5 .8). SFG corticalthickness measurements at each year were less correlated
(0.52,B, 0.75, P, .005), with a positive change between
years 1 and 2 (CI [0.01, 0.23] P 5 .03) that is, however, not
significant when accounting for multiple comparison correc-
tion (Y2/Y3 CI [20.25 0.15] P 5 .6 Y1/Y3 CI [20.06
0.21] P5 .3). SFG volumes expressed as % in ICV were all
highly correlated (0.57, B, 0.74, P, .001). Yearly volu-
metric changes were highly correlated with 2-year volu-
metric changes (0.62 , B , 0.81, P , .001). However, no
correlation was observed between SFG yearly volumetric
changes (i.e., Y1/Y2 and Y2/Y3). Paired t-tests revealed
only borderline significant differences between SFG vol-
umes as % in ICV in years 1 and 2 (P 5 .041).
The total volume of CSF (used as proxy for global atrophy)
showed a consistent pattern of increase in the LMCI group
only, and therefore, the magnitude of the changes in global at-
rophy between years were not significantly different (Y1/Y2
CI [20.91 2.6] P5 .3, Y2/Y3 CI [23.11 0.13] P5 .07,
Y1/Y3 CI [22.6 1 1.17] P 5 .4). In contrast to total CSF
volume, brain ventricular size experienced either no change
at year 1 (i.e., decrease of w1% considered to be within the
error margins) or a slight increase at year 2, in all cognitive
groups (Y1/Y2 CI [20.18 0.11 P 5 .7, Y2/Y3 CI
[20.39, 20.08], P 5 .004; Y1/Y3 CI [20.44, 20.07],
P 5 .01, Fig. 2). Paired samples correlation tests showed
that only the global CSF measurements from year 2 and
year 3 were modestly correlated (B 5 0.18, P 5 .010),
whereas all CSF ventricular measurements were highly corre-
lated (0.6 , B , 0.7, P , .0001).
All cognitive variables evaluated were highly correlated
(FAQ 0.80 , B , 0.92, MoCA 0.52 , B , 0.72, ECog vi-
suospatial 0.62 , B , 0.65, P , .0001), but only the mea-
surements of the FAQ were significantly different between
years (P , .0001). The changes between the yearly FAQ re-
sults (i.e., Y2 2 Y1 and Y3 2 Y2) and the changes in the
results of the FAQ across 2 years (i.e., Y3 2 Y1) were
also significantly different (P , .001) even after correcting
for multiple comparisons. The changes in the results from
the other two cognitive tests evaluated did not differ signif-
icantly.
From the 204 individuals pseudorandomly selected, only
177 had all variables to explore associations between
changes in the imaging (i.e., global brain atrophy) parame-
ters and changes in the outcome of the cognitive tests
selected. Regression analyses showed that changes in the
surface area of the SFG were associated with changes in
the outcome of the ECog visuospatial test (P 5 .046–
0.047) when the model was adjusted for age only (Fig. 3).
Adjusting the model also for baseline cognitive performance
(MMSE test results) did not change the significance in the
results. Including gender in the model increased the signifi-
cance in the associations (.01, P, .02 between years 1 and
2 and .02, P, .04 between years 1 and 3). Changes in the
SFG volume between years 1 and 3 were also associated
with changes in the results of the same test (i.e., ECog visuo-
spatial) (B 5 3.36, P 5 .009 in the model only adjusted for
Table 1
Descriptive statistics of the imaging and cognitive variables used
Cognitive group Parameter n
Mean (SD)
Y1 / Y2 (i.e., Y2 2 Y1) Y2 / Y3 (i.e., Y3 2 Y2) Y1 / Y3 (i.e., Y3 2 Y1)
CN Total CSF (% in ICV) 67 21.74 (13.78) 1.62 (12.67) 20.12 (13.53)
Ventricular CSF (% in ICV) 20.05 (1.20) 0.22 (1.21) 0.17 (1.35)
Average SFG surface area (mm2) 12 2529.92 (1389.19) 695.97 (1412.53) 135.33 (1405.31)
Mean SFG cortical thickness (mm) 20.11 (0.21) 20.10 (0.44) 20.23 (0.37)
SFG volume (% in ICV) 20.26 (0.51) 20.16 (0.69) 20.47 (0.84)
FAQ 65 0.34 (2.57) 20.11 (0.61) 0.23 (2.68)
MoCA 0.32 (5.65) 20.26 (4.76) 0.06 (5.57)
ECog visuospatial 0.11 (2.89) 0.20 (2.88) 0.31 (3.23)
EMCI Total CSF (% in ICV) 60 21.08 (10.52) 1.73 (10.48) 0.65 (12.49)
Ventricular CSF (% in ICV) 0.09 (0.94) 0.23 (1.05) 0.32 (1.16)
Average SFG surface area (mm2) 10 308.07 (1573.98) 609.77 (1092.89) 768.59 (1864.95)
Mean SFG cortical thickness (mm) 20.08 (0.26) 0.22 (0.57) 0.13 (0.49)
SFG volume (% in ICV) 20.0046 (0.44) 0.35 (0.29) 0.30 (0.74)
FAQ 57 1.03 (3.19) 0.67 (3.05) 1.70 (4.32)
MoCA 20.19 (6.56) 0.58 (4.77) 0.39 (7.03)
ECog visuospatial 1.79 (4.36) 21.10 (4.36) 0.68 (4.24)
LMCI Total CSF (% in ICV) 55 1.26 (10.38) 0.90 (9.51) 2.16 (10.76)
Ventricular CSF (% in ICV) 0.11 (0.81) 0.22 (0.65) 0.33 (1.04)
Average SFG surface area (mm2) 10 2264.88 (2571.63) 2116.05 (1964.07) 2857.12 (1868.00)
Mean SFG cortical thickness (mm) 20.14 (0.39) 0.12 (0.53) 20.03 (0.25)
SFG volume (% in ICV) 20.22 (0.50) 0.11 (0.45) 20.23 (0.68)
FAQ 54 0.68 (3.16) 1.96 (4.08) 2.65 (5.21)
MoCA 0.04 (6.67) 21.81 (7.27) 21.78 (8.27)
ECog visuospatial 21.28 (6.54) 1.59 (5.43) 0.31 (7.15)
AD Total CSF (% in ICV) 7 25.62 (17.68) 1.96 (1.30) 23.66 (17.67)
Ventricular CSF (% in ICV) 20.30 (1.34) 0.28 (0.27) 20.02 (1.39)
Average SFG surface area (mm2) 2 2557.58 (3.67) 21900.96 (1624.75) 22458.54 (1621.08)
Mean SFG cortical thickness (mm) 20.10 (0.21) 20.21 (0.39) 20.31 (0.17)
SFG volume (% in ICV) 20.19 (20.17) 20.60 (0.69) 20.79 (0.52)
FAQ 3 4.33 (2.89) 4.33 (1.15) 8.67 (4.04)
MoCA 22.67 (7.23) 210.00 (14.42) 212.67 (10.02)
ECog visuospatial 22.33 (6.11) 9.33 (10.60) 7.00 (5.20)
Abbreviations: FAQ, Functional Activities Questionnaire; SFG, superior frontal gyrus; AD, Alzheimer’s disease; CN, cognitively normal; ICV, intracranial
volume; EMCI, early mild cognitive impairment; LMCI, late mild cognitive impairment; ECog, Everyday Cognition; MoCA, Montreal Cognitive Assessment.
NOTE. The “2” sign represents average decrease of the parameter in a year (Y)/2-year time.
M.delC. Valdes Hernandez et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 10 (2018) 706-716710age, and B 5 3.32, P 5 .012 in the model adjusted for age
and MMSE). Adjusting for the rest of the covariates added
in stepwise manner did not change the significance of the as-
sociation. It only disappeared when interaction factors be-
tween covariates were additionally considered in the
models (Supplementary Table S2 Annex 2). The stepwise
general linear models also confirmed significance in the as-
sociation between changes in the surface area and the
outcome of the ECog visuospatial test between years 1 and
3 (B 5 0.001, P , .001, model fitness P , .001). The best
model fit had gender, baseline cognitive performance in
the MMSE test, years of education, family history of demen-
tia/AD, cardiovascular and endocrino-metabolic risk factors
as covariates and interaction factors between the cognitive
variables and the risk factors used as covariates
(Supplementary Table S2 Annex 2). No associations of the
changes in SFG surface area were found with changes in
the other two cognitive tests (i.e. FAQ and MoCA) and
neither between changes in the cortical thickness of the
SFG and changes in the outcome from any of the threecognitive tests, as the SFG measurements were excluded
as predictors in these models (Supplementary Table S2
Annex 2). However, interestingly, a general linear model
considering all covariates, and interactions between SFG
volume and age, SFG volume and family history of demen-
tia, and cognitive variables used as covariates and risk fac-
tors, showed association between 2-year changes in the
SFG volume and the outcome from MoCA
(Supplementary Table S2 Annex 2).
The results of the exploratory analysis to evaluate the asso-
ciations between changes in the general atrophy measure-
ments (total CSV and ventricular size) and the changes in
the outcome of the cognitive tests are shown in Table 2.
Best model fitness was achieved when the FAQ test results
were the outcome variable, and for changes between years
1 and 2 to 3 when the MoCA results were the outcome vari-
able. Among these models, the change in both general brain
atrophy indicators appeared to be associated with the change
in the FAQ test from years 2 to 3 andMoCA from years 1 to 3,
although at significance .001 , P , .05.
Fig. 2. Paired differences of the brainMRI measurements took on 2 consecutive years (first two columns from left to right) and 2 years apart (third column from
left to right) after being adjusted for head size (i.e., percent in ICV) show significance in the transitions from years 1 and 2 to 3 even after correcting for multiple
comparisons. Abbreviation: MRI, magnetic resonance imaging.
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and surface area of the SFG and the ECog visuospatial
test, we investigated whether our finding was in-line with
the published literature searching in Neurosynth for neural
correlates of visuospatial cognition. The search resulted in
224/11,406 studies in the database. The reverse inference
map resulting from the meta-analysis of the selected publi-
cations, after false discovery rate correction (expected false
discovery rate 0.01 as per website documentation) is shown
in Fig. 4. As can be appreciated, the SFG was one of the re-
gions that appear to be preferentially related with the term
visuospatial. The csv file with the results of the search is pro-
vided as Supplementary Material (Annex 3).
4. Discussion
4.1. Main findings
Two-year changes in the volume and surface area of the
SFG were associated with changes in the outcome of theECog visuospatial test. No differences across years and no
association were found between changes in the cortical
thickness of the SFG and changes in the outcome from any
of the three cognitive tests evaluated. The change in global
atrophy indicators showed an inconsistent pattern of associ-
ations (i.e., better model fitness corresponded with
.001 , P , .05) with the change in all the three cognitive
tests evaluated.
Cortical surface area is known to be a sensitive marker of
brain structure changes [9]. The SFG has been reported hav-
ing one of the greatest age-related surface area reductions in
normal brains [10]. However, in our CN group, this was not
observed, but rather in our LMCI and AD groups. In general,
despite the yearly changes in this parameter not being signif-
icant, the changes in a 2-year period were associated with the
changes in the ECog visuospatial test in the same period.
Studies evaluating visuospatial working memory tasks
have inconsistently detected activation in the prefrontal
cortical areas depending presumably on the type of memory
Fig. 3. Plot of the results of the regression model that had the 2-year change in mean surface area and age as predictors and the change in the results of the ECog
Visuospatial test in the same period as outcome variable.
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nance imaging study showed that visuospatial working
memory tasks engage a network of distributed brain areas
and areas in the dorsal visual pathway are engaged in mne-
monic processing of visuospatial information [19]. Further-
more, the meta-analysis including other 223 functional
magnetic resonance imaging studies showed the SFG being
a brain region preferentially related to the term visuospatial.
Our finding, not previously reported, is in-line with these
results.
Some factors may confound the fact that total brain atro-
phy, as measured by alterations in total and ventricular CSF
volume, did not have a consistent pattern of association with
change in the performance of the cognitive tests evaluated.
The automated software used to extract the CSF volumes
have previously been found to have varying degrees of accu-
racy with measurement errors in up to 12% of the MRI scans
[20,21]. These errors can also be accounted for by the effects
of pulsatile CSF flow and nonuniformities in clinical head
coils [20] despite the latter being corrected. The veins pre-
sent in the subdural space have also been shown to stiffen
and thicken with age, increasing their area of distribution,
which reduces levels of CSF and confounding its use as a
proxy for atrophy [22]. It must also be acknowledged that
we were assessing very subtle changes and, given our very
small AD population and the fact that no subjects changed
cognitive status during the analysis, these atrophy rates
were expected to be minimal [23,24]. These errors in
acquisition and confounding factors may explain thenegative % changes seen in the descriptive statistical
results (Table 1).4.2. Strengths and limitations
Some strengths of our study include the use of the ADNI
database, which encompasses a large variety of centers from
across the United States and Canada making site-specific
and general errors less likely. When correcting the semiauto-
matic ICVs and segmenting the SFG cortices, the investi-
gator was blind to the clinical data. Thus, there was no risk
of bias before image analysis. Using both an automated seg-
mentation and thorough manual correction process when
mapping the ICVs also decreased the risk of error from the
brain extraction that was used to generate the automatic vol-
umes of CSF used in the analyses of global atrophy. The
sample was of a moderately large longitudinal sample size
increasing the validity of the results.
However, we also acknowledge that the study has limita-
tions. Primarily, all the data acquired from the analysis are
progressive and relative to the measurements at the first
year that had data available. Thus, someone with AD may
have already declined structurally to a level where structural
changes are minimal and no longer perceivable. The 2-year
duration of the changes was a very small period to assess al-
terations, given the variability in annual rates of atrophy and
the subtlety of changes expected. Although the segmentation
adhered to a strict protocol, there was no interobserver reli-
ability testing. Furthermore, the cohort was a population of
Table 2
Results from the exploratory analysis (i.e., using stepwise general linear modeling) of the associations between changes in the general atrophy measurements
and the changes in the outcome of the cognitive tests
General linear model
Estimate (P value) for change
in total CSF volume (% in
ICV)
Estimate (P value) for change
























0.00126* 3.177 (0.009)* 241.028 (0.019)*








8.37e–05** 21.707 (0.0188)* 21.871 (0.0748)
ECog Visuospatial (Y1/Y2) age, MMSE, years education,
FH dementia, gender
0.00225* n/a n/a
ECog Visuospatial (Y1/Y3) CSF(Y1/Y3), age, MMSE,
FH dementia, gender,
EMRF
0.00187* 21.131 (0.0054)* n/a




0.0554 1.358 (0.0333)* 213.127 (0.0221)*
Abbreviations: FAQ, Functional Activities Questionnaire; CSF, % cerebrospinal fluid volume in ICV; BV, % brain ventricular volume in ICV; MMSE, Mini-
Mental State Examination results at baseline; FH dementia, family history of dementia; EMRF, endocrino-metabolic risk factors; CVRF, cardiovascular risk
factors; Y1, year 1; Y2, year 2; Y3, year 3; n/a, not applicable due to term not included as predictor in the model.
NOTE. *P , .05; **P , .001.
NOTE. Past medical history of cardiovascular risk factors refers to smoking, other risk factors mentioned in the participant’s medical history, and previous
medical reports of having (or not) any cardiovascular disease. The latter referred to/included the presence of coronary or peripheral artery disease, mild stroke,
hypertensive or rheumatic heart disease, cardiomyopathy, carditis, heart arrhythmia, or thromboembolic disease. The most common risk factors described in the
participant’s medical history are hypertension and hypercholesterolemia.
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base all agreed to have intensive serial procedures over a
long period of time and do not have lacunas, or mass lesions
at the time of recruitment, therefore not being representative
of the general population. In addition, the sample was highly
skewed away from patients with AD due to the blind selec-
tion process.4.3. Implications for future research
Future studies should reaffirm or refute findings from this
study to further define the role of the SFG in cognitive
decline. Using a larger, more evenly distributed sampleshould be a priority in the future to establish whether the re-
lationships found indeed exist or not. The better distribution
may be achieved from increasing the sample size; our low
AD cohort may have just been down to chance. Having
more longitudinal data than 3 years of brain scans would
also increase the time for structural changes to manifest.
Furthermore, having intraobserver reliability testing of the
SFG segmentations would be required.
The cognitive tests chosen should be expanded in the
future to incorporate a wide battery of cognitive tests. We
suggest that future analyses focus on specific aspects of
cognition such as organization or verbal learning, avoiding
general screening tools that incorporate several cognitive
Fig. 4. Reverse inferencemap of the brain regions that were preferentially related to the term visuospatial in the 224 studies selected. The locations that show the
red-to-white foci appear reported more often in articles that include the term visuospatial in their abstracts than articles that do not.
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would be interesting to use this same method to evaluate
other areas in the prefrontal cortex found to have changes
in relative cerebral glucose metabolic rate in the article by
Drzezga et al. [3].Acknowledgments
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1. Systematic review: Current literature on the role of
age-related changes in the superior frontal gyrus
(SFG) identified using conventional structural mag-
netic resonance imaging, in cognitive decline, was
systematically reviewed in Web of Science. One
study that used positron emission tomography linked
metabolic alterations to the SFG to cognitive decline.
Whether these metabolic changes are indicative of
structural atrophy in a period of 2 consecutive years,
which could be screened for at a larger scale using
noninvasive, less expensive structural imaging is
unknown and was therefore the aim of our investi-
gation.
2. Interpretations: Our findings suggest that subtle
changes in the average measurement of surface
area—but not cortical thickness—of the SFG influ-
ence the outcome of the visuospatial cognitive func-
tion, whereas a 2-year period yields inconclusive
results on the global brain atrophy changes and their
association with cognitive changes in such period.
Indeed, the SFG resulted as one of the more promi-
nent regions preferentially related to the term visuo-
spatial as per 224/11406 functional magnetic
resonance imaging studies.
3. Future directions: We propose to repeat the analysis
in a wider sample more representative of the general
population, focus on specific aspects of cognition
such as organization or verbal learning, avoiding
general screening tools that incorporate several
cognitive processes as these may be less sensitive
to subtle changes and study whether differences
between observers/segmentation methods affect the
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